Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in sost-deficient mice

Alexander G. Robling, Rajendra Kedlaya, Shana N. Ellis, Paul J. Childress, Joseph P. Bidwell, Teresita Bellido, Charles H. Turner

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

PTH is a potent calcium-regulating factor that has skeletal anabolic effects when administered intermittently or catabolic effects when maintained at consistently high levels. Bone cells express PTH receptors, but the cellular responses to PTH in bone are incompletely understood. Wnt signaling has recently been implicated in the osteo-anabolic response to the hormone. Specifically, the Sost gene, a major antagonist of Wnt signaling, is down-regulated by PTH exposure. We investigated this mechanism by treating Sost-deficient mice and their wild-type littermates with anabolic and catabolic regimens of PTH and measuring the skeletal responses. Male Sost+/+ and Sost-/- mice were injected daily with human PTH 1-34 (0, 30, or 90 μg/kg) for 6 wk. Female Sost+/+ and Sost-/- mice were continuously infused with vehicle or high-dose PTH (40 μg/kg · d) for 3 wk. Dual energy x-ray absorptiometry-derived measures of intermittent PTH (iPTH)-induced bone gain were impaired in Sost-/- mice. Further probing revealed normal or enhanced iPTH-induced cortical bone formation rates but concomitant increases in cortical porosity among Sost-/- mice. Distal femur trabecular bone was highly responsive to iPTH in Sost-/- mice. Continuous PTH (cPTH) infusion resulted in equal bone loss in Sost+/+ and Sost -/- mice as measured by dual energy x-ray absorptiometry. However, distal femur trabecular bone, but not lumbar spine trabecular bone,was spared the bone-wasting effects of cPTH in Sost-/- mice. These results suggest that changes in Sost expression are not required for iPTH-induced anabolism. iPTH-induced resorption of cortical bone might be overstimulated in Sost-deficient environments. Furthermore, Sost deletion protects some trabecular compartments, but not cortical compartments, from bone loss induced by high-dose PTH infusion.

Original languageEnglish (US)
Pages (from-to)2963-2975
Number of pages13
JournalEndocrinology
Volume152
Issue number8
DOIs
StatePublished - Aug 1 2011

Fingerprint

Teriparatide
Bone and Bones
Femur
X-Rays
Anabolic Agents
Porosity
Parathyroid Hormone
Osteogenesis
Spine
Hormones
Calcium

ASJC Scopus subject areas

  • Endocrinology

Cite this

Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in sost-deficient mice. / Robling, Alexander G.; Kedlaya, Rajendra; Ellis, Shana N.; Childress, Paul J.; Bidwell, Joseph P.; Bellido, Teresita; Turner, Charles H.

In: Endocrinology, Vol. 152, No. 8, 01.08.2011, p. 2963-2975.

Research output: Contribution to journalArticle

@article{c2e1ad15ed9e4f90bc7b18b25bd7c23b,
title = "Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in sost-deficient mice",
abstract = "PTH is a potent calcium-regulating factor that has skeletal anabolic effects when administered intermittently or catabolic effects when maintained at consistently high levels. Bone cells express PTH receptors, but the cellular responses to PTH in bone are incompletely understood. Wnt signaling has recently been implicated in the osteo-anabolic response to the hormone. Specifically, the Sost gene, a major antagonist of Wnt signaling, is down-regulated by PTH exposure. We investigated this mechanism by treating Sost-deficient mice and their wild-type littermates with anabolic and catabolic regimens of PTH and measuring the skeletal responses. Male Sost+/+ and Sost-/- mice were injected daily with human PTH 1-34 (0, 30, or 90 μg/kg) for 6 wk. Female Sost+/+ and Sost-/- mice were continuously infused with vehicle or high-dose PTH (40 μg/kg · d) for 3 wk. Dual energy x-ray absorptiometry-derived measures of intermittent PTH (iPTH)-induced bone gain were impaired in Sost-/- mice. Further probing revealed normal or enhanced iPTH-induced cortical bone formation rates but concomitant increases in cortical porosity among Sost-/- mice. Distal femur trabecular bone was highly responsive to iPTH in Sost-/- mice. Continuous PTH (cPTH) infusion resulted in equal bone loss in Sost+/+ and Sost -/- mice as measured by dual energy x-ray absorptiometry. However, distal femur trabecular bone, but not lumbar spine trabecular bone,was spared the bone-wasting effects of cPTH in Sost-/- mice. These results suggest that changes in Sost expression are not required for iPTH-induced anabolism. iPTH-induced resorption of cortical bone might be overstimulated in Sost-deficient environments. Furthermore, Sost deletion protects some trabecular compartments, but not cortical compartments, from bone loss induced by high-dose PTH infusion.",
author = "Robling, {Alexander G.} and Rajendra Kedlaya and Ellis, {Shana N.} and Childress, {Paul J.} and Bidwell, {Joseph P.} and Teresita Bellido and Turner, {Charles H.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1210/en.2011-0049",
language = "English (US)",
volume = "152",
pages = "2963--2975",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in sost-deficient mice

AU - Robling, Alexander G.

AU - Kedlaya, Rajendra

AU - Ellis, Shana N.

AU - Childress, Paul J.

AU - Bidwell, Joseph P.

AU - Bellido, Teresita

AU - Turner, Charles H.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - PTH is a potent calcium-regulating factor that has skeletal anabolic effects when administered intermittently or catabolic effects when maintained at consistently high levels. Bone cells express PTH receptors, but the cellular responses to PTH in bone are incompletely understood. Wnt signaling has recently been implicated in the osteo-anabolic response to the hormone. Specifically, the Sost gene, a major antagonist of Wnt signaling, is down-regulated by PTH exposure. We investigated this mechanism by treating Sost-deficient mice and their wild-type littermates with anabolic and catabolic regimens of PTH and measuring the skeletal responses. Male Sost+/+ and Sost-/- mice were injected daily with human PTH 1-34 (0, 30, or 90 μg/kg) for 6 wk. Female Sost+/+ and Sost-/- mice were continuously infused with vehicle or high-dose PTH (40 μg/kg · d) for 3 wk. Dual energy x-ray absorptiometry-derived measures of intermittent PTH (iPTH)-induced bone gain were impaired in Sost-/- mice. Further probing revealed normal or enhanced iPTH-induced cortical bone formation rates but concomitant increases in cortical porosity among Sost-/- mice. Distal femur trabecular bone was highly responsive to iPTH in Sost-/- mice. Continuous PTH (cPTH) infusion resulted in equal bone loss in Sost+/+ and Sost -/- mice as measured by dual energy x-ray absorptiometry. However, distal femur trabecular bone, but not lumbar spine trabecular bone,was spared the bone-wasting effects of cPTH in Sost-/- mice. These results suggest that changes in Sost expression are not required for iPTH-induced anabolism. iPTH-induced resorption of cortical bone might be overstimulated in Sost-deficient environments. Furthermore, Sost deletion protects some trabecular compartments, but not cortical compartments, from bone loss induced by high-dose PTH infusion.

AB - PTH is a potent calcium-regulating factor that has skeletal anabolic effects when administered intermittently or catabolic effects when maintained at consistently high levels. Bone cells express PTH receptors, but the cellular responses to PTH in bone are incompletely understood. Wnt signaling has recently been implicated in the osteo-anabolic response to the hormone. Specifically, the Sost gene, a major antagonist of Wnt signaling, is down-regulated by PTH exposure. We investigated this mechanism by treating Sost-deficient mice and their wild-type littermates with anabolic and catabolic regimens of PTH and measuring the skeletal responses. Male Sost+/+ and Sost-/- mice were injected daily with human PTH 1-34 (0, 30, or 90 μg/kg) for 6 wk. Female Sost+/+ and Sost-/- mice were continuously infused with vehicle or high-dose PTH (40 μg/kg · d) for 3 wk. Dual energy x-ray absorptiometry-derived measures of intermittent PTH (iPTH)-induced bone gain were impaired in Sost-/- mice. Further probing revealed normal or enhanced iPTH-induced cortical bone formation rates but concomitant increases in cortical porosity among Sost-/- mice. Distal femur trabecular bone was highly responsive to iPTH in Sost-/- mice. Continuous PTH (cPTH) infusion resulted in equal bone loss in Sost+/+ and Sost -/- mice as measured by dual energy x-ray absorptiometry. However, distal femur trabecular bone, but not lumbar spine trabecular bone,was spared the bone-wasting effects of cPTH in Sost-/- mice. These results suggest that changes in Sost expression are not required for iPTH-induced anabolism. iPTH-induced resorption of cortical bone might be overstimulated in Sost-deficient environments. Furthermore, Sost deletion protects some trabecular compartments, but not cortical compartments, from bone loss induced by high-dose PTH infusion.

UR - http://www.scopus.com/inward/record.url?scp=79960746000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960746000&partnerID=8YFLogxK

U2 - 10.1210/en.2011-0049

DO - 10.1210/en.2011-0049

M3 - Article

C2 - 21652726

AN - SCOPUS:79960746000

VL - 152

SP - 2963

EP - 2975

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 8

ER -